Just googled it. looks interesting. any other info on it.
They are coming to market in 2024 ideally. They have done a lot of animal studies and are doing human trials now.
Their team at ASRA seemed very reasonable. Not overly markety or over-hyped (unlike SPR and Nevro). The people at their booth seemed to actually understand the science of their product, and were very interested in having people be hands on.
Seems easy to deploy, and unlike Sprint it won't get pulled out, and it would be easier for patient's to wear the generator only when they need it.
Possible downsides pointed out by the team, is that depending on which nerve you target, there can be some cutaneous sensation from the trans-cutaneous energy transmission. Also placement of the tip very close to the nerve is likely more important than Sprint since they cannot match Sprint's max amplitude due to the trans-cutaneous transmission.
The fact that the people at their booth were willing to discuss its limitations earned them huge points in my book.
That was in stark contrast to the Nevro rep who stopped just short of telling me every single patient needs a Nevro trial but did tell me that after one or two interventions fail I should just try a Nevro on anyone from CRPS to axial back pain. Maybe he's right, but felt like an aggressive pitch to put devices in people.
Maybe I am still a bit disillusioned from ASRA.
ETA - The Neuronoff Injectrode people also gave me a sick slinky for my son. He is playing with it now. So they have to be good people.